Biophan Technologies, Inc. Announces Amendment To $30 Million Common Stock Purchase Agreement

ROCHESTER, N.Y.--(BUSINESS WIRE)--Jan. 9, 2006--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation biomedical technology, has amended an earlier agreement with financing partner SBI Brightline XI, LLC for the sale of up to 10 million shares of its common stock. The shares are to be sold in tranches of 1 million shares each at a weighted average price of $3.00 per share, assuming the full $30 million were utilized. The amendment clarifies Biophan’s right to determine the dates of sale of share traunches to SBI.

MORE ON THIS TOPIC